Commodore Capital is a healthcare investment firm. We use a science-driven approach to invest in innovative companies that are developing medical products to meaningfully improve patients’ lives. The fund is designed to make long term investments in small-cap public and late-stage private biopharmaceutical companies.
| Website | http://www.commodorecapital.com |
| Revenue | $2 million |
| Employees | 14 (14 on RocketReach) |
| Founded | 2019 |
| Address | 444 Madison Ave 35th Floor, New York, New York 10022, US |
| Phone | (917) 970-1730 |
| Industry | Investment Management, Finance General, Finance |
| Keywords | Healthcare Investment, Medical Products, Biotechnology Investment, Pharmaceutical Investment, Life Sciences Investment, Healthcare Fund, Medical Technology, Patient Care, Innovative Healthcare, Investment Fund, Private Equity Healthcare, Venture Capital Healthcare, Medical Innovation, Healthcare Venture Capital, Biotech Fund, Health Tech Investment, Improving Patient Lives |
| Competitors | Fidelity Investments, BlackRock, Brookfield Asset Management, Apollo Global Management, Inc., KKR, The Carlyle Group, TPG, Man Group, Winton, Highfields Capital +30 more (view full list) |
| SIC | SIC Code 67 Companies, SIC Code 679 Companies |
| NAICS | NAICS Code 5239 Companies, NAICS Code 52 Companies, NAICS Code 523 Companies |
Looking for a particular Commodore Capital, LP employee's phone or email?
The Commodore Capital, LP annual revenue was $2 million in 2026.
Egen Atkinson is the Co-Founder and Managing Partner of Commodore Capital, LP.
14 people are employed at Commodore Capital, LP.
Commodore Capital, LP is based in New York, New York.
The NAICS codes for Commodore Capital, LP are [5239, 52, 523].
The SIC codes for Commodore Capital, LP are [67, 679].